{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T22:44:42Z","timestamp":1794091482232,"version":"4.8.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.biopha.2025.117903","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T07:36:38Z","timestamp":1739259398000},"page":"117903","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Sodium Butyrate ameliorates pain and mood disorders in a mouse model of Parkinson disease"],"prefix":"10.1016","volume":"184","author":[{"given":"Carmen","family":"Avagliano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"De Caro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariarosaria","family":"Cuozzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Roberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"La Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.117903_bib1","first-page":"217","article-title":"Activation of endocannabinoid transmission induces antidepressant-like effects in rats","volume":"59","author":"Adamczyk","year":"2008","journal-title":"J. Physiol. Pharm."},{"key":"10.1016\/j.biopha.2025.117903_bib2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13024-021-00427-6","article-title":"Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson\u2019s disease","volume":"16","author":"Aho","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.biopha.2025.117903_bib3","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.3390\/ijms23126367","article-title":"Dual-hit model of Parkinson\u2019s disease: impact of dysbiosis on 6-hydroxydopamine-insulted mice\u2014neuroprotective and anti-inflammatory effects of butyrate","volume":"23","author":"Avagliano","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.117903_bib4","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.phrs.2016.09.004","article-title":"Palmitoylethanolamide protects mice against 6-OHDA-induced neurotoxicity and endoplasmic reticulum stress: In vivo and in vitro evidence","volume":"113","author":"Avagliano","year":"2016","journal-title":"Pharm. Res"},{"key":"10.1016\/j.biopha.2025.117903_bib5","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson\u2019s disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2025.117903_bib6","doi-asserted-by":"crossref","first-page":"11312","DOI":"10.1074\/jbc.M211609200","article-title":"The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids","volume":"278","author":"Brown","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.117903_bib7","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s00702-016-1649-8","article-title":"The impact of Parkinson disease on patients\u2019 sexuality and relationship","volume":"124","author":"Buhmann","year":"2017","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.biopha.2025.117903_bib8","first-page":"S37","article-title":"Management of pain in Parkinson\u2019s disease","volume":"10","author":"Buhmann","year":"2020","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.biopha.2025.117903_bib9","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.phrs.2018.11.033","article-title":"Evidence of a PPAR\u03b3-mediated mechanism in the ability of Withania somnifera to attenuate tolerance to the antinociceptive effects of morphine","volume":"139","author":"Caputi","year":"2019","journal-title":"Pharm. Res"},{"key":"10.1016\/j.biopha.2025.117903_bib10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neuropharm.2012.11.017","article-title":"Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-\u03b1 receptor activation in a genetic model of absence epilepsy","volume":"69","author":"Citraro","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2025.117903_bib11","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/19390211.2021.2005733","article-title":"Palmitoylethanolamide: a potential alternative to cannabidiol","volume":"20","author":"Clayton","year":"2023","journal-title":"J. Diet. Suppl."},{"key":"10.1016\/j.biopha.2025.117903_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113528","article-title":"Oral sodium butyrate supplementation ameliorates paclitaxel-induced behavioral and intestinal dysfunction","volume":"153","author":"Cristiano","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2025.117903_bib13","doi-asserted-by":"crossref","first-page":"422","DOI":"10.2174\/187152709789824615","article-title":"Signal Transduction via Cannabinoid Receptors","volume":"8","author":"Dalton","year":"2009","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.biopha.2025.117903_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.549191","article-title":"Pain modulation in WAG\/Rij epileptic rats (A genetic model of absence epilepsy): effects of biological and pharmacological histone deacetylase inhibitors","volume":"11","author":"De Caro","year":"2020","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2025.117903_bib15","first-page":"1","article-title":"Palmitoylethanolamide is a disease-modifying agent in peripheral neuropathy: pain relief and neuroprotection share a PPAR-alpha-mediated mechanism","volume":"2013","author":"Di Cesare Mannelli","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.biopha.2025.117903_bib16","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.expneurol.2019.02.007","article-title":"Parkinson\u2019s disease and pain: modulation of nociceptive circuitry in a rat model of nigrostriatal lesion","volume":"315","author":"Domenici","year":"2019","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.biopha.2025.117903_bib17","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1124\/jpet.116.236182","article-title":"Palmitoylethanolamide reverses paclitaxel-induced allodynia in mice","volume":"359","author":"Donvito","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2025.117903_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/gut.2006.093484","article-title":"PPARgamma as a new therapeutic target in inflammatory bowel diseases","volume":"55","author":"Dubuquoy","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2025.117903_bib19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.neubiorev.2018.10.004","article-title":"The hidden side of Parkinson\u2019s disease: Studying pain, anxiety and depression in animal models","volume":"96","author":"Faivre","year":"2019","journal-title":"Neurosci. Biobehav Rev."},{"key":"10.1016\/j.biopha.2025.117903_bib20","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ejphar.2018.07.043","article-title":"Hydroxytyrosol butyrate inhibits 6-OHDA-induced apoptosis through activation of the Nrf2\/HO-1 axis in SH-SY5Y cells","volume":"834","author":"Funakohi-Tago","year":"2018","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.biopha.2025.117903_bib21","doi-asserted-by":"crossref","DOI":"10.1111\/adb.13421","article-title":"Interrelated involvement of the endocannabinoid\/endovanilloid (TRPV1) systems and epigenetic processes in anxiety- and working memory impairment-related behavioural effects of nicotine as a stressor","volume":"29","author":"Hayase","year":"2024","journal-title":"Addict. Biol."},{"key":"10.1016\/j.biopha.2025.117903_bib22","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.smim.2014.04.001","article-title":"Stress regulates endocannabinoid-CB1 receptor signaling","volume":"26","author":"Hillard","year":"2014","journal-title":"Semin Immunol."},{"key":"10.1016\/j.biopha.2025.117903_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2021.111376","article-title":"Neuroprotective effects of short-chain fatty acids in MPTP induced mice model of Parkinson\u2019s disease","volume":"150","author":"Hou","year":"2021","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.biopha.2025.117903_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2005.02.023","article-title":"Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson\u2019s disease in mice","volume":"162","author":"Iancu","year":"2005","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.biopha.2025.117903_bib25","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14473","article-title":"Neuroprotective effects of gemfibrozil in neurological disorders: focus on inflammation and molecular mechanisms","volume":"30","author":"Ivraghi","year":"2024","journal-title":"CNS Neurosci. Ther."},{"issue":"1979","key":"10.1016\/j.biopha.2025.117903_bib26","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1126\/science.aaf8924","article-title":"Pain regulation by non-neuronal cells and inflammation","volume":"354","author":"Ji","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.biopha.2025.117903_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135426","article-title":"Hesperidin downregulates kinases lrrk2 and gsk3\u03b2 in a 6-OHDA induced Parkinson\u2019s disease model","volume":"740","author":"Kesh","year":"2021","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2025.117903_bib28","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0006-291X(02)00294-2","article-title":"Butyrate reduces colonic paracellular permeability by enhancing PPAR\u03b3 activation","volume":"293","author":"Kinoshita","year":"2002","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.biopha.2025.117903_bib29","doi-asserted-by":"crossref","first-page":"92","DOI":"10.14802\/jmd.15003","article-title":"Many faces of Parkinson\u2019s disease: non-motor symptoms of Parkinson\u2019s disease","volume":"8","author":"Lee","year":"2015","journal-title":"J. Mov. Disord."},{"key":"10.1016\/j.biopha.2025.117903_bib30","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/MCO.0b013e32835665fa","article-title":"Butyrate: implications for intestinal function","volume":"15","author":"Leonel","year":"2012","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.biopha.2025.117903_bib31","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jpain.2012.10.005","article-title":"Epigenetic regulation of opioid-induced hyperalgesia, dependence, and tolerance in mice","volume":"14","author":"Liang","year":"2013","journal-title":"J. Pain."},{"key":"10.1016\/j.biopha.2025.117903_bib32","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00281-018-0672-2","article-title":"Neurogenic inflammation in fibromyalgia","volume":"40","author":"Littlejohn","year":"2018","journal-title":"Semin Immunopathol."},{"key":"10.1016\/j.biopha.2025.117903_bib33","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jns.2017.08.3235","article-title":"Sodium butyrate exerts protective effect against Parkinson\u2019s disease in mice via stimulation of glucagon like peptide-1","volume":"381","author":"Liu","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.biopha.2025.117903_bib34","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1080\/003655202317316105","article-title":"Butyrate inhibits NF-\u03baB activation in lamina propria macrophages of patients with ulcerative colitis","volume":"37","author":"L\u00fchrs","year":"2002","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.biopha.2025.117903_bib35","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/j.pain.2013.03.023","article-title":"Endocannabinoids: A unique opportunity to develop multitarget analgesics","volume":"154","author":"Maione","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.biopha.2025.117903_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068626","article-title":"Effects of sodium butyrate and its synthetic amide derivative on liver inflammation and glucose tolerance in an animal model of steatosis induced by high fat diet","volume":"8","author":"Mattace Raso","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.117903_bib37","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","article-title":"The pathogenesis of Parkinson\u2019s disease","volume":"403","author":"Morris","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2025.117903_bib38","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1124\/jpet.106.101287","article-title":"Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling","volume":"318","author":"Patel","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2025.117903_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.658433","article-title":"Endocannabinoids and precision medicine for mood disorders and suicide","volume":"12","author":"Pinna","year":"2021","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.biopha.2025.117903_bib40","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/mds.23135","article-title":"Parkinson\u2019s disease symptoms: the patient\u2019s perspective","volume":"25","author":"Politis","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.biopha.2025.117903_bib41","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nri.2016.42","article-title":"Gut microbiota, metabolites and host immunity","volume":"16","author":"Rooks","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2025.117903_bib42","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.phrs.2015.11.026","article-title":"Sodium butyrate and its synthetic amide derivative modulate nociceptive behaviors in mice","volume":"103","author":"Russo","year":"2016","journal-title":"Pharm. Res"},{"key":"10.1016\/j.biopha.2025.117903_bib43","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nrn.2017.62","article-title":"Non-motor features of Parkinson disease","volume":"18","author":"Schapira","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.biopha.2025.117903_bib44","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neuropharm.2007.08.011","article-title":"The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition","volume":"54","author":"Scherma","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2025.117903_bib45","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1016\/j.molimm.2007.04.010","article-title":"Involvement of different nuclear hormone receptors in butyrate-mediated inhibition of inducible NF\u03baB signalling","volume":"44","author":"Schwab","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.biopha.2025.117903_bib46","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/ejp.2096","article-title":"Pain and Parkinson\u2019s disease: Current mechanism and management updates","volume":"27","author":"Viseux","year":"2023","journal-title":"Eur. J. Pain."},{"key":"10.1016\/j.biopha.2025.117903_bib47","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nrn3617","article-title":"Neurogenic neuroinflammation: inflammatory CNS reactions in response to neuronal activity","volume":"15","author":"Xanthos","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.biopha.2025.117903_bib48","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.brainres.2017.12.004","article-title":"Sodium butyrate abolishes lipopolysaccharide-induced depression-like behaviors and hippocampal microglial activation in mice","volume":"1680","author":"Yamawaki","year":"2018","journal-title":"Brain Res"},{"key":"10.1016\/j.biopha.2025.117903_bib49","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S1734-1140(11)70596-5","article-title":"Short communication - N-palmitoylethanolamide, an endocannabinoid, exhibits antidepressant effects in the forced swim test and the tail suspension test in mice","volume":"63","author":"Yu","year":"2011","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.biopha.2025.117903_bib50","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","article-title":"Role of neuroinflammation in neurodegeneration development","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target Ther."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225000976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225000976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T23:44:45Z","timestamp":1741045485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225000976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":50,"alternative-id":["S0753332225000976"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.117903","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sodium Butyrate ameliorates pain and mood disorders in a mouse model of Parkinson disease","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.117903","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117903"}}